Global CRISPR/Cas9 Market Insights and Forecast to 2028

Report ID: 1751834 | Published Date: Jan 2025 | No. of Page: 116 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global CRISPR/Cas9 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Genome Editing
        1.2.3 Genetic Engineering
        1.2.4 gRNA Database/Gene Librar
        1.2.5 CRISPR Plasmid
        1.2.6 Human Stem Cells
        1.2.7 Genetically Modified Organisms/Crops
        1.2.8 Cell Line Engineering
    1.3 Market by Application
        1.3.1 Global CRISPR/Cas9 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Biotechnology Companies
        1.3.3 Pharmaceutical Companies
        1.3.4 Academic Institutes
        1.3.5 Research and Development Institutes
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global CRISPR/Cas9 Market Perspective (2017-2028)
    2.2 CRISPR/Cas9 Growth Trends by Region
        2.2.1 CRISPR/Cas9 Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 CRISPR/Cas9 Historic Market Size by Region (2017-2022)
        2.2.3 CRISPR/Cas9 Forecasted Market Size by Region (2023-2028)
    2.3 CRISPR/Cas9 Market Dynamics
        2.3.1 CRISPR/Cas9 Industry Trends
        2.3.2 CRISPR/Cas9 Market Drivers
        2.3.3 CRISPR/Cas9 Market Challenges
        2.3.4 CRISPR/Cas9 Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top CRISPR/Cas9 Players by Revenue
        3.1.1 Global Top CRISPR/Cas9 Players by Revenue (2017-2022)
        3.1.2 Global CRISPR/Cas9 Revenue Market Share by Players (2017-2022)
    3.2 Global CRISPR/Cas9 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by CRISPR/Cas9 Revenue
    3.4 Global CRISPR/Cas9 Market Concentration Ratio
        3.4.1 Global CRISPR/Cas9 Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by CRISPR/Cas9 Revenue in 2021
    3.5 CRISPR/Cas9 Key Players Head office and Area Served
    3.6 Key Players CRISPR/Cas9 Product Solution and Service
    3.7 Date of Enter into CRISPR/Cas9 Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR/Cas9 Breakdown Data by Type
    4.1 Global CRISPR/Cas9 Historic Market Size by Type (2017-2022)
    4.2 Global CRISPR/Cas9 Forecasted Market Size by Type (2023-2028)
5 CRISPR/Cas9 Breakdown Data by Application
    5.1 Global CRISPR/Cas9 Historic Market Size by Application (2017-2022)
    5.2 Global CRISPR/Cas9 Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America CRISPR/Cas9 Market Size (2017-2028)
    6.2 North America CRISPR/Cas9 Market Size by Type
        6.2.1 North America CRISPR/Cas9 Market Size by Type (2017-2022)
        6.2.2 North America CRISPR/Cas9 Market Size by Type (2023-2028)
        6.2.3 North America CRISPR/Cas9 Market Share by Type (2017-2028)
    6.3 North America CRISPR/Cas9 Market Size by Application
        6.3.1 North America CRISPR/Cas9 Market Size by Application (2017-2022)
        6.3.2 North America CRISPR/Cas9 Market Size by Application (2023-2028)
        6.3.3 North America CRISPR/Cas9 Market Share by Application (2017-2028)
    6.4 North America CRISPR/Cas9 Market Size by Country
        6.4.1 North America CRISPR/Cas9 Market Size by Country (2017-2022)
        6.4.2 North America CRISPR/Cas9 Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe CRISPR/Cas9 Market Size (2017-2028)
    7.2 Europe CRISPR/Cas9 Market Size by Type
        7.2.1 Europe CRISPR/Cas9 Market Size by Type (2017-2022)
        7.2.2 Europe CRISPR/Cas9 Market Size by Type (2023-2028)
        7.2.3 Europe CRISPR/Cas9 Market Share by Type (2017-2028)
    7.3 Europe CRISPR/Cas9 Market Size by Application
        7.3.1 Europe CRISPR/Cas9 Market Size by Application (2017-2022)
        7.3.2 Europe CRISPR/Cas9 Market Size by Application (2023-2028)
        7.3.3 Europe CRISPR/Cas9 Market Share by Application (2017-2028)
    7.4 Europe CRISPR/Cas9 Market Size by Country
        7.4.1 Europe CRISPR/Cas9 Market Size by Country (2017-2022)
        7.4.2 Europe CRISPR/Cas9 Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific CRISPR/Cas9 Market Size (2017-2028)
    8.2 Asia-Pacific CRISPR/Cas9 Market Size by Type
        8.2.1 Asia-Pacific CRISPR/Cas9 Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific CRISPR/Cas9 Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific CRISPR/Cas9 Market Share by Type (2017-2028)
    8.3 Asia-Pacific CRISPR/Cas9 Market Size by Application
        8.3.1 Asia-Pacific CRISPR/Cas9 Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific CRISPR/Cas9 Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific CRISPR/Cas9 Market Share by Application (2017-2028)
    8.4 Asia-Pacific CRISPR/Cas9 Market Size by Region
        8.4.1 Asia-Pacific CRISPR/Cas9 Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific CRISPR/Cas9 Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America CRISPR/Cas9 Market Size (2017-2028)
    9.2 Latin America CRISPR/Cas9 Market Size by Type
        9.2.1 Latin America CRISPR/Cas9 Market Size by Type (2017-2022)
        9.2.2 Latin America CRISPR/Cas9 Market Size by Type (2023-2028)
        9.2.3 Latin America CRISPR/Cas9 Market Share by Type (2017-2028)
    9.3 Latin America CRISPR/Cas9 Market Size by Application
        9.3.1 Latin America CRISPR/Cas9 Market Size by Application (2017-2022)
        9.3.2 Latin America CRISPR/Cas9 Market Size by Application (2023-2028)
        9.3.3 Latin America CRISPR/Cas9 Market Share by Application (2017-2028)
    9.4 Latin America CRISPR/Cas9 Market Size by Country
        9.4.1 Latin America CRISPR/Cas9 Market Size by Country (2017-2022)
        9.4.2 Latin America CRISPR/Cas9 Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa CRISPR/Cas9 Market Size (2017-2028)
    10.2 Middle East & Africa CRISPR/Cas9 Market Size by Type
        10.2.1 Middle East & Africa CRISPR/Cas9 Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa CRISPR/Cas9 Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa CRISPR/Cas9 Market Share by Type (2017-2028)
    10.3 Middle East & Africa CRISPR/Cas9 Market Size by Application
        10.3.1 Middle East & Africa CRISPR/Cas9 Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa CRISPR/Cas9 Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa CRISPR/Cas9 Market Share by Application (2017-2028)
    10.4 Middle East & Africa CRISPR/Cas9 Market Size by Country
        10.4.1 Middle East & Africa CRISPR/Cas9 Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa CRISPR/Cas9 Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Caribou Biosciences
        11.1.1 Caribou Biosciences Company Details
        11.1.2 Caribou Biosciences Business Overview
        11.1.3 Caribou Biosciences CRISPR/Cas9 Introduction
        11.1.4 Caribou Biosciences Revenue in CRISPR/Cas9 Business (2017-2022)
        11.1.5 Caribou Biosciences Recent Developments
    11.2 Integrated DNA Technologies(IDT)
        11.2.1 Integrated DNA Technologies(IDT) Company Details
        11.2.2 Integrated DNA Technologies(IDT) Business Overview
        11.2.3 Integrated DNA Technologies(IDT) CRISPR/Cas9 Introduction
        11.2.4 Integrated DNA Technologies(IDT) Revenue in CRISPR/Cas9 Business (2017-2022)
        11.2.5 Integrated DNA Technologies(IDT) Recent Developments
    11.3 CRISPR Therapeutics
        11.3.1 CRISPR Therapeutics Company Details
        11.3.2 CRISPR Therapeutics Business Overview
        11.3.3 CRISPR Therapeutics CRISPR/Cas9 Introduction
        11.3.4 CRISPR Therapeutics Revenue in CRISPR/Cas9 Business (2017-2022)
        11.3.5 CRISPR Therapeutics Recent Developments
    11.4 Merck
        11.4.1 Merck Company Details
        11.4.2 Merck Business Overview
        11.4.3 Merck CRISPR/Cas9 Introduction
        11.4.4 Merck Revenue in CRISPR/Cas9 Business (2017-2022)
        11.4.5 Merck Recent Developments
    11.5 Mirus Bio
        11.5.1 Mirus Bio Company Details
        11.5.2 Mirus Bio Business Overview
        11.5.3 Mirus Bio CRISPR/Cas9 Introduction
        11.5.4 Mirus Bio Revenue in CRISPR/Cas9 Business (2017-2022)
        11.5.5 Mirus Bio Recent Developments
    11.6 Editas Medicine
        11.6.1 Editas Medicine Company Details
        11.6.2 Editas Medicine Business Overview
        11.6.3 Editas Medicine CRISPR/Cas9 Introduction
        11.6.4 Editas Medicine Revenue in CRISPR/Cas9 Business (2017-2022)
        11.6.5 Editas Medicine Recent Developments
    11.7 Takara Bio
        11.7.1 Takara Bio Company Details
        11.7.2 Takara Bio Business Overview
        11.7.3 Takara Bio CRISPR/Cas9 Introduction
        11.7.4 Takara Bio Revenue in CRISPR/Cas9 Business (2017-2022)
        11.7.5 Takara Bio Recent Developments
    11.8 Thermo Fisher Scientific
        11.8.1 Thermo Fisher Scientific Company Details
        11.8.2 Thermo Fisher Scientific Business Overview
        11.8.3 Thermo Fisher Scientific CRISPR/Cas9 Introduction
        11.8.4 Thermo Fisher Scientific Revenue in CRISPR/Cas9 Business (2017-2022)
        11.8.5 Thermo Fisher Scientific Recent Developments
    11.9 Horizon Discovery Group
        11.9.1 Horizon Discovery Group Company Details
        11.9.2 Horizon Discovery Group Business Overview
        11.9.3 Horizon Discovery Group CRISPR/Cas9 Introduction
        11.9.4 Horizon Discovery Group Revenue in CRISPR/Cas9 Business (2017-2022)
        11.9.5 Horizon Discovery Group Recent Developments
    11.10 Intellia Therapeutics
        11.10.1 Intellia Therapeutics Company Details
        11.10.2 Intellia Therapeutics Business Overview
        11.10.3 Intellia Therapeutics CRISPR/Cas9 Introduction
        11.10.4 Intellia Therapeutics Revenue in CRISPR/Cas9 Business (2017-2022)
        11.10.5 Intellia Therapeutics Recent Developments
    11.11 Agilent Technologies
        11.11.1 Agilent Technologies Company Details
        11.11.2 Agilent Technologies Business Overview
        11.11.3 Agilent Technologies CRISPR/Cas9 Introduction
        11.11.4 Agilent Technologies Revenue in CRISPR/Cas9 Business (2017-2022)
        11.11.5 Agilent Technologies Recent Developments
    11.12 Cellecta
        11.12.1 Cellecta Company Details
        11.12.2 Cellecta Business Overview
        11.12.3 Cellecta CRISPR/Cas9 Introduction
        11.12.4 Cellecta Revenue in CRISPR/Cas9 Business (2017-2022)
        11.12.5 Cellecta Recent Developments
    11.13 GenScript
        11.13.1 GenScript Company Details
        11.13.2 GenScript Business Overview
        11.13.3 GenScript CRISPR/Cas9 Introduction
        11.13.4 GenScript Revenue in CRISPR/Cas9 Business (2017-2022)
        11.13.5 GenScript Recent Developments
    11.14 GeneCopoeia
        11.14.1 GeneCopoeia Company Details
        11.14.2 GeneCopoeia Business Overview
        11.14.3 GeneCopoeia CRISPR/Cas9 Introduction
        11.14.4 GeneCopoeia Revenue in CRISPR/Cas9 Business (2017-2022)
        11.14.5 GeneCopoeia Recent Developments
    11.15 Synthego
        11.15.1 Synthego Company Details
        11.15.2 Synthego Business Overview
        11.15.3 Synthego CRISPR/Cas9 Introduction
        11.15.4 Synthego Revenue in CRISPR/Cas9 Business (2017-2022)
        11.15.5 Synthego Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global CRISPR/Cas9 Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Genome Editing
    Table 3. Key Players of Genetic Engineering
    Table 4. Key Players of gRNA Database/Gene Librar
    Table 5. Key Players of CRISPR Plasmid
    Table 6. Key Players of Human Stem Cells
    Table 7. Key Players of Genetically Modified Organisms/Crops
    Table 8. Key Players of Cell Line Engineering
    Table 9. Global CRISPR/Cas9 Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 10. Global CRISPR/Cas9 Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global CRISPR/Cas9 Market Size by Region (2017-2022) & (US$ Million)
    Table 12. Global CRISPR/Cas9 Market Share by Region (2017-2022)
    Table 13. Global CRISPR/Cas9 Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 14. Global CRISPR/Cas9 Market Share by Region (2023-2028)
    Table 15. CRISPR/Cas9 Market Trends
    Table 16. CRISPR/Cas9 Market Drivers
    Table 17. CRISPR/Cas9 Market Challenges
    Table 18. CRISPR/Cas9 Market Restraints
    Table 19. Global CRISPR/Cas9 Revenue by Players (2017-2022) & (US$ Million)
    Table 20. Global CRISPR/Cas9 Revenue Share by Players (2017-2022)
    Table 21. Global Top CRISPR/Cas9 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR/Cas9 as of 2021)
    Table 22. Ranking of Global Top CRISPR/Cas9 Companies by Revenue (US$ Million) in 2021
    Table 23. Global 5 Largest Players Market Share by CRISPR/Cas9 Revenue (CR5 and HHI) & (2017-2022)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players CRISPR/Cas9 Product Solution and Service
    Table 26. Date of Enter into CRISPR/Cas9 Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global CRISPR/Cas9 Market Size by Type (2017-2022) & (US$ Million)
    Table 29. Global CRISPR/Cas9 Revenue Market Share by Type (2017-2022)
    Table 30. Global CRISPR/Cas9 Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 31. Global CRISPR/Cas9 Revenue Market Share by Type (2023-2028)
    Table 32. Global CRISPR/Cas9 Market Size by Application (2017-2022) & (US$ Million)
    Table 33. Global CRISPR/Cas9 Revenue Share by Application (2017-2022)
    Table 34. Global CRISPR/Cas9 Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 35. Global CRISPR/Cas9 Revenue Share by Application (2023-2028)
    Table 36. North America CRISPR/Cas9 Market Size by Type (2017-2022) & (US$ Million)
    Table 37. North America CRISPR/Cas9 Market Size by Type (2023-2028) & (US$ Million)
    Table 38. North America CRISPR/Cas9 Market Size by Application (2017-2022) & (US$ Million)
    Table 39. North America CRISPR/Cas9 Market Size by Application (2023-2028) & (US$ Million)
    Table 40. North America CRISPR/Cas9 Market Size by Country (2017-2022) & (US$ Million)
    Table 41. North America CRISPR/Cas9 Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Europe CRISPR/Cas9 Market Size by Type (2017-2022) & (US$ Million)
    Table 43. Europe CRISPR/Cas9 Market Size by Type (2023-2028) & (US$ Million)
    Table 44. Europe CRISPR/Cas9 Market Size by Application (2017-2022) & (US$ Million)
    Table 45. Europe CRISPR/Cas9 Market Size by Application (2023-2028) & (US$ Million)
    Table 46. Europe CRISPR/Cas9 Market Size by Country (2017-2022) & (US$ Million)
    Table 47. Europe CRISPR/Cas9 Market Size by Country (2023-2028) & (US$ Million)
    Table 48. Asia Pacific CRISPR/Cas9 Market Size by Type (2017-2022) & (US$ Million)
    Table 49. Asia Pacific CRISPR/Cas9 Market Size by Type (2023-2028) & (US$ Million)
    Table 50. Asia Pacific CRISPR/Cas9 Market Size by Application (2017-2022) & (US$ Million)
    Table 51. Asia Pacific CRISPR/Cas9 Market Size by Application (2023-2028) & (US$ Million)
    Table 52. Asia Pacific CRISPR/Cas9 Market Size by Region (2017-2022) & (US$ Million)
    Table 53. Asia Pacific CRISPR/Cas9 Market Size by Region (2023-2028) & (US$ Million)
    Table 54. Latin America CRISPR/Cas9 Market Size by Type (2017-2022) & (US$ Million)
    Table 55. Latin America CRISPR/Cas9 Market Size by Type (2023-2028) & (US$ Million)
    Table 56. Latin America CRISPR/Cas9 Market Size by Application (2017-2022) & (US$ Million)
    Table 57. Latin America CRISPR/Cas9 Market Size by Application (2023-2028) & (US$ Million)
    Table 58. Latin America CRISPR/Cas9 Market Size by Country (2017-2022) & (US$ Million)
    Table 59. Latin America CRISPR/Cas9 Market Size by Country (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa CRISPR/Cas9 Market Size by Type (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa CRISPR/Cas9 Market Size by Type (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa CRISPR/Cas9 Market Size by Application (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa CRISPR/Cas9 Market Size by Application (2023-2028) & (US$ Million)
    Table 64. Middle East and Africa CRISPR/Cas9 Market Size by Country (2017-2022) & (US$ Million)
    Table 65. Middle East and Africa CRISPR/Cas9 Market Size by Country (2023-2028) & (US$ Million)
    Table 66. Caribou Biosciences Company Details
    Table 67. Caribou Biosciences Business Overview
    Table 68. Caribou Biosciences CRISPR/Cas9 Product
    Table 69. Caribou Biosciences Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 70. Caribou Biosciences Recent Developments
    Table 71. Integrated DNA Technologies(IDT) Company Details
    Table 72. Integrated DNA Technologies(IDT) Business Overview
    Table 73. Integrated DNA Technologies(IDT) CRISPR/Cas9 Product
    Table 74. Integrated DNA Technologies(IDT) Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 75. Integrated DNA Technologies(IDT) Recent Developments
    Table 76. CRISPR Therapeutics Company Details
    Table 77. CRISPR Therapeutics Business Overview
    Table 78. CRISPR Therapeutics CRISPR/Cas9 Product
    Table 79. CRISPR Therapeutics Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 80. CRISPR Therapeutics Recent Developments
    Table 81. Merck Company Details
    Table 82. Merck Business Overview
    Table 83. Merck CRISPR/Cas9 Product
    Table 84. Merck Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 85. Merck Recent Developments
    Table 86. Mirus Bio Company Details
    Table 87. Mirus Bio Business Overview
    Table 88. Mirus Bio CRISPR/Cas9 Product
    Table 89. Mirus Bio Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 90. Mirus Bio Recent Developments
    Table 91. Editas Medicine Company Details
    Table 92. Editas Medicine Business Overview
    Table 93. Editas Medicine CRISPR/Cas9 Product
    Table 94. Editas Medicine Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 95. Editas Medicine Recent Developments
    Table 96. Takara Bio Company Details
    Table 97. Takara Bio Business Overview
    Table 98. Takara Bio CRISPR/Cas9 Product
    Table 99. Takara Bio Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 100. Takara Bio Recent Developments
    Table 101. Thermo Fisher Scientific Company Details
    Table 102. Thermo Fisher Scientific Business Overview
    Table 103. Thermo Fisher Scientific CRISPR/Cas9 Product
    Table 104. Thermo Fisher Scientific Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 105. Thermo Fisher Scientific Recent Developments
    Table 106. Horizon Discovery Group Company Details
    Table 107. Horizon Discovery Group Business Overview
    Table 108. Horizon Discovery Group CRISPR/Cas9 Product
    Table 109. Horizon Discovery Group Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 110. Horizon Discovery Group Recent Developments
    Table 111. Intellia Therapeutics Company Details
    Table 112. Intellia Therapeutics Business Overview
    Table 113. Intellia Therapeutics CRISPR/Cas9 Product
    Table 114. Intellia Therapeutics Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 115. Intellia Therapeutics Recent Developments
    Table 116. Agilent Technologies Company Details
    Table 117. Agilent Technologies Business Overview
    Table 118. Agilent Technologies CRISPR/Cas9 Product
    Table 119. Agilent Technologies Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 120. Agilent Technologies Recent Developments
    Table 121. Cellecta Company Details
    Table 122. Cellecta Business Overview
    Table 123. Cellecta CRISPR/Cas9 Product
    Table 124. Cellecta Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 125. Cellecta Recent Developments
    Table 126. GenScript Company Details
    Table 127. GenScript Business Overview
    Table 128. GenScript CRISPR/Cas9 Product
    Table 129. GenScript Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 130. GenScript Recent Developments
    Table 131. GeneCopoeia Company Details
    Table 132. GeneCopoeia Business Overview
    Table 133. GeneCopoeia CRISPR/Cas9 Product
    Table 134. GeneCopoeia Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 135. GeneCopoeia Recent Developments
    Table 136. Synthego Company Details
    Table 137. Synthego Business Overview
    Table 138. Synthego CRISPR/Cas9 Product
    Table 139. Synthego Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 140. Synthego Recent Developments
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global CRISPR/Cas9 Market Share by Type: 2021 VS 2028
    Figure 2. Genome Editing Features
    Figure 3. Genetic Engineering Features
    Figure 4. gRNA Database/Gene Librar Features
    Figure 5. CRISPR Plasmid Features
    Figure 6. Human Stem Cells Features
    Figure 7. Genetically Modified Organisms/Crops Features
    Figure 8. Cell Line Engineering Features
    Figure 9. Global CRISPR/Cas9 Market Share by Application: 2021 VS 2028
    Figure 10. Biotechnology Companies Case Studies
    Figure 11. Pharmaceutical Companies Case Studies
    Figure 12. Academic Institutes Case Studies
    Figure 13. Research and Development Institutes Case Studies
    Figure 14. CRISPR/Cas9 Report Years Considered
    Figure 15. Global CRISPR/Cas9 Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 16. Global CRISPR/Cas9 Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global CRISPR/Cas9 Market Share by Region: 2021 VS 2028
    Figure 18. Global CRISPR/Cas9 Market Share by Players in 2021
    Figure 19. Global Top CRISPR/Cas9 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR/Cas9 as of 2021)
    Figure 20. The Top 10 and 5 Players Market Share by CRISPR/Cas9 Revenue in 2021
    Figure 21. North America CRISPR/Cas9 Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. North America CRISPR/Cas9 Market Size Market Share by Type (2017-2028)
    Figure 23. North America CRISPR/Cas9 Market Size Market Share by Application (2017-2028)
    Figure 24. North America CRISPR/Cas9 Market Size Share by Country (2017-2028)
    Figure 25. United States CRISPR/Cas9 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Canada CRISPR/Cas9 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Europe CRISPR/Cas9 Market Size YoY (2017-2028) & (US$ Million)
    Figure 28. Europe CRISPR/Cas9 Market Size Market Share by Type (2017-2028)
    Figure 29. Europe CRISPR/Cas9 Market Size Market Share by Application (2017-2028)
    Figure 30. Europe CRISPR/Cas9 Market Size Share by Country (2017-2028)
    Figure 31. Germany CRISPR/Cas9 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. France CRISPR/Cas9 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. U.K. CRISPR/Cas9 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Italy CRISPR/Cas9 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Russia CRISPR/Cas9 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Nordic Countries CRISPR/Cas9 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific CRISPR/Cas9 Market Size YoY (2017-2028) & (US$ Million)
    Figure 38. Asia Pacific CRISPR/Cas9 Market Size Market Share by Type (2017-2028)
    Figure 39. Asia Pacific CRISPR/Cas9 Market Size Market Share by Application (2017-2028)
    Figure 40. Asia Pacific CRISPR/Cas9 Market Size Share by Region (2017-2028)
    Figure 41. China CRISPR/Cas9 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Japan CRISPR/Cas9 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. South Korea CRISPR/Cas9 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Southeast Asia CRISPR/Cas9 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. India CRISPR/Cas9 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Australia CRISPR/Cas9 Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 47. Latin America CRISPR/Cas9 Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Latin America CRISPR/Cas9 Market Size Market Share by Type (2017-2028)
    Figure 49. Latin America CRISPR/Cas9 Market Size Market Share by Application (2017-2028)
    Figure 50. Latin America CRISPR/Cas9 Market Size Share by Country (2017-2028)
    Figure 51. Mexico CRISPR/Cas9 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Brazil CRISPR/Cas9 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa CRISPR/Cas9 Market Size YoY (2017-2028) & (US$ Million)
    Figure 54. Middle East and Africa CRISPR/Cas9 Market Size Market Share by Type (2017-2028)
    Figure 55. Middle East and Africa CRISPR/Cas9 Market Size Market Share by Application (2017-2028)
    Figure 56. Middle East and Africa CRISPR/Cas9 Market Size Share by Country (2017-2028)
    Figure 57. Turkey CRISPR/Cas9 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Saudi Arabia CRISPR/Cas9 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. UAE CRISPR/Cas9 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 60. Caribou Biosciences Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 61. Integrated DNA Technologies(IDT) Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 62. CRISPR Therapeutics Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 63. Merck Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 64. Mirus Bio Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 65. Editas Medicine Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 66. Takara Bio Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 67. Thermo Fisher Scientific Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 68. Horizon Discovery Group Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 69. Intellia Therapeutics Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 70. Agilent Technologies Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 71. Cellecta Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 72. GenScript Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 73. GeneCopoeia Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 74. Synthego Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Caribou Biosciences
Integrated DNA Technologies(IDT)
CRISPR Therapeutics
Merck
Mirus Bio
Editas Medicine
Takara Bio
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
Agilent Technologies
Cellecta
GenScript
GeneCopoeia
Synthego
Frequently Asked Questions
CRISPR/Cas9 report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
CRISPR/Cas9 report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
CRISPR/Cas9 report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Laboratory Balances

Laboratory Balances market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More